Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
HANGZHOU, China and SUZHOU, China and NEW YORK, June 17, 2021 (GLOBE NEWSWIRE) -- AnHeart Therapeutics Co., Ltd. (“AnHeart”), a clinical stage oncology company focused on underserved patients in...
-
HANGZHOU, China, June 06, 2021 (GLOBE NEWSWIRE) -- AnHeart Therapeutics Co., Ltd (“AnHeart”), a clinical stage oncology company focused on underserved patients in global markets, together with...
-
HANGZHOU, China and SUZHOU, China and NEW YORK, May 31, 2021 (GLOBE NEWSWIRE) -- AnHeart Therapeutics Co., Ltd. (“AnHeart”), a clinical stage oncology company focused on underserved patients in...
-
HANGZHOU, China and NEW YORK, May 19, 2021 (GLOBE NEWSWIRE) -- AnHeart Therapeutics Co., Ltd. (“AnHeart”), a clinical stage oncology company focused on underserved patients in global markets,...
-
HANGZHOU, China and NEW YORK, Oct. 29, 2020 (GLOBE NEWSWIRE) -- AnHeart Therapeutics, Co., Ltd. (“AnHeart”), a clinical stage oncology company focused on underserved patients in global markets,...
-
Expanding Oncology Pipeline to Three Novel Molecules Following its Series A+ Financing Round HANGZHOU, China and NEW YORK, Sept. 07, 2020 (GLOBE NEWSWIRE) -- AnHeart Therapeutics, Co., Ltd....
-
HANGZHOU, China and NEW YORK, Aug. 09, 2020 (GLOBE NEWSWIRE) -- AnHeart Therapeutics, Co., Ltd. (“AnHeart”), a clinical stage oncology company focused on underserved patients in global markets, has...
-
SHANGHAI, China and NEW YORK, July 24, 2020 (GLOBE NEWSWIRE) -- AnHeart Therapeutics, Co., Ltd. (“AnHeart”), a clinical stage oncology company focused on underserved patients in global markets,...
-
SHANGHAI, China and NEW YORK, July 21, 2020 (GLOBE NEWSWIRE) -- AnHeart Therapeutics, Co., Ltd. (“AnHeart”), a clinical stage oncology company focused on underserved patients in global markets,...
-
HANGZHOU, China and NEW YORK, July 15, 2020 (GLOBE NEWSWIRE) -- AnHeart Therapeutics, Co., Ltd. (“AnHeart”), a clinical stage oncology company focused on underserved patients in global markets,...